Shanghai Hile Bio-Technology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 85.08 million compared to CNY 101.07 million a year ago. Revenue was CNY 85.08 million compared to CNY 101.07 million a year ago. Net income was CNY 10.6 million compared to CNY 13.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.016. Diluted earnings per share from continuing operations was CNY 0.016.